4d
Study Finds on MSNWhen Good Cells Turn Bad: Scientists Discover Why Psoriasis Won’t Go AwayDiscover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.
Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.
Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...
J&J's head of immunodermatology Liza O'Dowd said that the "robust results" with its oral IL-23 drug have the potential to ...
Psoriasis experts say the PASI is not practical ... "Sometimes a patient comes back and says, I'm doing [the treatment] and it keeps coming back and I'm sick of it, or maybe the BSA is increasing ...
Steven Daniel Daveluy, MD, FAAD, discussed how artificial intelligence (AI) can leverage extensive patient data and guide dermatologists to improve early diagnosis and treatment of rare dermatological ...
Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.
Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to care people with psoriasis face.
20d
Verywell Health on MSNUnderstanding Scalp Psoriasis and How to Treat ItMedically reviewed by Katlein Franca, MD When psoriasis affects the scalp, it causes thick, silvery-white or gray scales that may be inflamed and itchy. You may also feel burning or other discomfort.
Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.
Wearing a hat won't make you bald in and of itself, Thacker says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results